News for 'Morepen'

Morepen to be listed on Luxembourg bourse

Morepen Laboratories will soon be listed on Luxembourg Stock Exchange with its global depository receipts getting 'fully subscribed' by European institutional investors and the company will seek to list these fresh shares in the domestic market as we

Morepen FD repayment plan cleared by CLB

Morepen files suit against Swiss firm over contrac

Morepen Laboratories has filed a suit before the Delhi high court against the Swiss-based DiaMed Scientific Laboratories

Morepen files global patent for Desloratadine

Indian drugmaker Morepen Laboratories Ltd has filed an international patent for the manufacturing process of Desloratadine, the Bombay Stock Exchange said on Wednesday.

Morepen expects sales to rise by Rs 100 cr

Morepen Laboratories is all set to gain from the 180-day marketing exclusivity granted to Geneva Pharmaceuticals Inc for Loratadine in the U S.

Morepen gets relief for few days

Morepen set to rope in foreign ally to clear dues

'Sputnik V provides immunity for a longer duration'

'Its efficacy is 97.6 per cent.'

Which company owns the brand Burnol?

Take the Rediff Biz Quiz and find out how much you know about brands in India.

6 major companies found manufacturing 'substandard' drugs

Alkem Labs was issued drug alerts twice last year -- in June and July -- for its drug Glimekem.

Russia reaches out to Kerala for Sputnik V plant

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms outside that country. Shine Jacob and Sohini Das report.

Ask Ajit: 'New to investing. Need help'

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Trade margins capped at 70% for oximeters, BP meters, other medical devices

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products.

ASK AJIT: Stocks To Buy, Hold, Sell

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

ASK AJIT: New Stocks To Buy?

'Kindly advise about the following stocks. Can I hold or exit?'

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Rajiv Kochhar's Avista Advisory earned Rs 300 crore in the last four years

Avista helped some companies restructure their debt in such a way that overseas investors had to take a steep haircut

Ask Ajit: 'Advice for small-time investor'

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

'Hold or exit from these stocks?'

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

'Can I invest in the stockmarket now?'

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.